Back to User profile » Dr Jie-pin Li
Papers published by Dr Jie-pin Li:
An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)
Huang P, Hu YD, Liu YJ, Li JP, Zhang YH
Journal of Hepatocellular Carcinoma 2023, 10:959-978
Published Date: 22 June 2023
An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)
Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:497-515
Published Date: 30 March 2023
Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma
Sha Y, Mao AQ, Liu YJ, Li JP, Gong YT, Xiao D, Huang J, Gao YW, Wu MY, Shen H
Pharmacogenomics and Personalized Medicine 2023, 16:153-172
Published Date: 4 March 2023
Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis
Yin Y, Xu ZY, Liu YJ, Huang W, Zhang Q, Li JP, Zou X
Journal of Hepatocellular Carcinoma 2022, 9:885-900
Published Date: 27 August 2022
USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
Zhang Q, Liu YJ, Li JP, Zeng SH, Shen H, Han M, Guo S, Liu SL, Zou X
Journal of Inflammation Research 2022, 15:3065-3082
Published Date: 24 May 2022
An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment
Liu YJ, Han M, Li JP, Zeng SH, Ye QW, Yin ZH, Liu SL, Zou X
Journal of Inflammation Research 2022, 15:2461-2476
Published Date: 15 April 2022
DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma
Liu YJ, Zeng SH, Qian WH, Tao MX, Zhu YY, Li JP
Pharmacogenomics and Personalized Medicine 2022, 15:261-275
Published Date: 24 March 2022
Prognostic Value of LHFPL Tetraspan Subfamily Member 6 (LHFPL6) in Gastric Cancer: A Study Based on Bioinformatics Analysis and Experimental Validation
Liu YJ, Yin SY, Zeng SH, Hu YD, Wang MQ, Huang P, Li JP
Pharmacogenomics and Personalized Medicine 2021, 14:1483-1504
Published Date: 20 November 2021
DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis
Liu YJ, Li JP, Zeng SH, Han M, Liu SL, Zou X
Pharmacogenomics and Personalized Medicine 2021, 14:1151-1168
Published Date: 16 September 2021
FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration
Liu YJ, Li JP, Zhang Y, Nie MJ, Zhang YH, Liu SL, Zou X
OncoTargets and Therapy 2021, 14:4099-4117
Published Date: 6 July 2021